便DNA中的甲基化变化:结直肠癌查的标志物?
Hannes M Müller1, Michael Oberwalder, Heidi Fiegl
1Department of General and Transplant Surgery, Medical University Innsbruck, A-6020 Innsbruck, Austria.
Lancet (London, England)
|April 20, 2004
概括
早期检测结直肠癌是可以使用便中的特定DNA甲基化标记物. 便DNA中的SFRP2甲基化显示为检测结直肠癌的非侵入性生物标志物具有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 基因甲基化是结直肠癌中经常观察到的分子变化.
- 非侵入性生物标志物对于早期结肠直肠癌检测和查至关重要.
研究的目的:
- 评估使用便DNA甲基化用于结直肠癌鉴定的可行性,敏感性和特异性.
- 为了确定大便中的特定DNA甲基化标记,用于结直肠癌诊断.
主要方法:
- 从结直肠癌患者和对照个体的便DNA分析.
- 使用MethyLight分析来评估DNA甲基化模式.
- 检查了三个独立的患者队列,以验证标记.
主要成果:
- 在便样本中,SFRP2甲基化被确定为结直肠癌的敏感标记物.
- 在训练组 (n=23) 中,SFRP2甲基化显示了90%的灵敏度和77%的特异性.
- 在一个独立的试验组 (n=26) 中,SFRP2甲基化显示出77%的灵敏度和77%的特异性.
结论:
- 便DNA中的SFRP2甲基化代表了一种有前途的基于DNA的单一生物标志物,用于检测结直肠癌.
- 需要进一步的研究,以确定是否结合遗传和表观遗传标记可以改善早期结直肠癌的识别.
相关概念视频
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...


